Publications by authors named "Matthew D Rousculp"

Claim this Profile
T
The shadow of reactogenicity: Parental hesitancy due to prior vaccine experiences.
Manuela H Gschwend, Emmanuel Faust, Matthew D Rousculp, Seth Toback

Vaccine· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of NVX-CoV2373 and BNT162b2 COVID-19 Vaccination in South Korean Adolescents.
Eunseon Gwak, Seung-Ah Choe, Kyuwon Kim, Erdenetuya Bolormaa, Manuela H Gschwend, Matthew D Rousculp

Pediatr Infect Dis J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precautionary Health Behaviours as Potential Confounders in COVID-19 Vaccine Effectiveness Studies.
Chloé Wyndham-Thomas, Leonie de Munter, Kok Yew Ngew, Sanskruti Gaikwad, Konstantina Chatzikonstantinidou, Matthew D Rousculp

Vaccines (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness of NVX-CoV2373 and BNT162b2 mRNA COVID-19 vaccination in South Korea.
Eunseon Gwak, Seung-Ah Choe, Kyuwon Kim, Erdenetuya Bolormaa, Jonathan Fix, Matthew D Rousculp

Vaccine· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, immunogenicity, and safety of the Novavax COVID-19 vaccine in immunocompromised patients: A targeted literature review.
Manuela H Gschwend, Anthony M Marchese, Dirk Poelaert, Brandy Warren, Matthew D Rousculp

Vaccine· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative effectiveness of homologous NVX-CoV2373 and BNT162b2 COVID-19 vaccinations in South Korea.
Eunseon Gwak, Seung-Ah Choe, Erdenetuya Bolormaa, Young June Choe, Chengbin Wang, Matthew D Rousculp

Vaccine· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local and systemic reactogenicity after mRNA and protein-based COVID-19 vaccines compared to meningococcal vaccine (MenACWY) in a UK blinded, randomized phase 2 trial (COV-BOOST).
Anthony M Marchese, Hadi Beyhaghi, Matthew D Rousculp, Vivian Huang, Xinxue Liu

Vaccine· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Vaccine Preferences in General Populations in Canada, Germany, the United Kingdom, and the United States: Discrete Choice Experiment.
David Salisbury, Jeffrey V Lazarus, Nancy Waite, Clara Lehmann, Sumitra Sri Bhashyam, Matthew D Rousculp

JMIR Public Health Surveill· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reactogenicity Differences between Adjuvanted, Protein-Based and Messenger Ribonucleic Acid (mRNA)-Based COVID-19 Vaccines.
Matthew D Rousculp, Kelly Hollis, Ryan Ziemiecki, Dawn Odom, Anthony M Marchese

Vaccines (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Going Forward: Potential Impact of Protein-Based COVID-19 Vaccination Coverage on Population Outcomes and Costs in the United States.
Kyle Paret, Hadi Beyhaghi, William L Herring, Josephine Mauskopf, Lesley G Shane, Matthew D Rousculp

Vaccines (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden and Impact of Reactogenicity among Adults Receiving COVID-19 Vaccines in the United States and Canada: Results from a Prospective Observational Study.
Matthew D Rousculp, Kelly Hollis, Ryan Ziemiecki, Dawn Odom, Anthony M Marchese

Vaccines (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of the NVX-CoV2373 COVID-19 vaccine in randomized placebo-controlled clinical trials.
Katherine Smith, Karim Hegazy, Miranda R Cai, Irene McKnight, Matthew D Rousculp

Vaccine· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of adherence to treatment with inhaled corticosteroids/long-acting β-agonists on asthma outcomes in the United States.
Carlyne M Averell, François Laliberté, Guillaume Germain, Mei Sheng Duh, Matthew D Rousculp

Ther Adv Respir Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth in health care data causing an evolution in the pharmaceutical industry.
J Alan Menius, Matthew D Rousculp

N C Med J· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of a quadrivalent Ann Arbor strain live attenuated influenza vaccine delivered using a blow-fill-seal device in adults: a randomized, active-controlled study*.
Eric A Sheldon, Robert Jeanfreau, Joseph A Sliman, Supoat Charenkavanich, Matthew D Rousculp

Influenza Other Respir Viruses· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The comparative value of various employer-sponsored influenza vaccination clinics.
Richard K Zimmerman, Ann E Wiringa, Mary Patricia Nowalk, Chyongchiou J Lin, Matthew D Rousculp

J Occup Environ Med· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elementary school-located influenza vaccine programs: key stakeholder experiences from initiation to continuation.
Valerie Williams, Matthew D Rousculp, Mark Price, Theresa Coles, Michelle Therrien

J Sch Nurs· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agreement between Internet-based self- and proxy-reported health care resource utilization and administrative health care claims.
Liisa Palmer, Stephen S Johnston, Matthew D Rousculp, Bong-Chul Chu, Kristin L Nichol

Value Health· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Children's perceptions of influenza illness and preferences for influenza vaccine.
Emuella M Flood, Stan L Block, Matthew C Hall, Matthew D Rousculp, Victoria M Divino

J Pediatr Health Care· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A survey of children's preferences for influenza vaccine attributes.
Emuella M Flood, Kellie J Ryan, Matthew D Rousculp, Kathleen M Beusterien, Stan L Block

Vaccine· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parent preferences for pediatric influenza vaccine attributes.
Emuella M Flood, Kellie J Ryan, Matthew D Rousculp, Kathleen M Beusterien, Victoria M Divino

Clin Pediatr (Phila)· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A valuable summary of various experiences with school-located influenza vaccination programs.
Christopher S Ambrose, Matthew D Rousculp

J Sch Nurs· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attending work while sick: implication of flexible sick leave policies.
Matthew D Rousculp, Stephen S Johnston, Liisa A Palmer, Bong-Chul Chu, Parthiv J Mahadevia

J Occup Environ Med· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parents' decision-making regarding vaccinating their children against influenza: A web-based survey.
Emuella M Flood, Matthew D Rousculp, Kellie J Ryan, Kathleen M Beusterien, Victoria M Divino

Clin Ther· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opening and continuing the discussion on influenza vaccination timing.
Kellie J Ryan, Matthew D Rousculp

Am J Manag Care· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis